Transcriptomics

Dataset Information

2

Transcription profiling of human basal-like breast cancer - in vitro and in vivo Analysis of B-Myb


ABSTRACT: The basal-like breast cancer subtype portends a poor clinical prognosis, and a defining feature of this subtype is the high expression of genes in the “proliferation signature”. B-Myb, a member of the MYB protein family of transcription factors, is highly expressed in the proliferation signature and is amplified and overexpressed in a variety of tumor types, including breast. In this report we demonstrated that B-Myb is highly expressed in basal-like breast cancer relative to the other subtypes, and B-Myb expression alone is prognostic. We also identified an association between a nonsynonymous B-Myb germline variant (S427G, rs2070235) and an increased risk of having a basal-like breast cancer among patients with breast cancer. The expression of B-Myb, or the S427G variant, was manipulated in vitro and we observed that in hTERT-immortalized normal Human Mammary Epithelial Cells, but not basal-like tumor-derived lines, cells ectopically expressing B-Myb showed increased sensitivity to DNA topoisomerase II inhibitors, but not other chemotherapeutics; in addition, microarray analyses of B-Myb overexpressing cells identified many G2/M targets as being preferentially induced. These results again suggest that B-Myb is involved in G2/M cell cycle control and that dysregulation of B-Myb may contribute to an increased sensitivity to a specific class of chemotherapeutic agents in vitro, and potentially in vivo. These data provide insight into the influence of B-Myb in human breast cancer, which is of potential clinical importance for determining disease risk and for guiding treatment. Experiment Overall Design: Reference VS. Samples

ORGANISM(S): Homo sapiens  

SUBMITTER: Charles Perou  

PROVIDER: E-GEOD-11429 | ArrayExpress | 2009-01-18

SECONDARY ACCESSION(S): GSE11429PRJNA106453

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

In vitro and in vivo analysis of B-Myb in basal-like breast cancer.

Thorner A R AR   Hoadley K A KA   Parker J S JS   Winkel S S   Millikan R C RC   Perou C M CM  

Oncogene 20081201 5


A defining feature of basal-like breast cancer, a breast cancer subtype with poor clinical prognosis, is the high expression of 'proliferation signature' genes. We identified B-Myb, a MYB family transcription factor that is often amplified and overexpressed in many tumor types, as being highly expressed in the proliferation signature. However, the roles of B-Myb in disease progression, and its mammary-specific transcriptional targets, are poorly understood. Here, we showed that B-Myb expression  ...[more]

Similar Datasets

2010-10-15 | E-GEOD-21371 | ArrayExpress
2011-05-26 | E-GEOD-26411 | ArrayExpress
2012-05-29 | E-GEOD-28712 | ArrayExpress
2011-09-21 | E-GEOD-30489 | ArrayExpress
2013-12-31 | E-GEOD-47358 | ArrayExpress
2010-07-06 | E-GEOD-14457 | ArrayExpress
2014-06-30 | E-GEOD-52783 | ArrayExpress
2009-04-01 | E-GEOD-10885 | ArrayExpress
2013-07-12 | E-GEOD-43467 | ArrayExpress
2014-07-29 | E-GEOD-41119 | ArrayExpress